PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong.\', \'School of Biology, Lomonosov Moscow State University, Moscow, Russia.\', \'Intel Corporation, Santa Clara, California, United States of America.\', \'Intel Corporation, Bangalore India.\', \'Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America.\', \'University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States of America.\', \'Autophagy Inflammation and Metabolism Center of Biomedical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.\', \'Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.\', \'Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.\', \'Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, Ilinois, United States of America.\', \'Pritzker School of Molecular Engineering, University of Chicago, Chicago, Ilinois, United States of America.\', \'Department of Surgery, Section of Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, Ilinois, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pcbi.1009183
?:hasPublicationType
?:journal
  • PLoS computational biology
is ?:pmid of
?:pmid
?:pmid
  • 34260589
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.097
?:rankingScore_hIndex
  • 138
?:title
  • COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all